Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 109067
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.109067
Table 2 Clinical and biochemical characteristics in the diabetic gastric motility disorders group and non-diabetic gastric motility disorders group, n (%)/mean ± SD/median (25th-75th percentiles)
Variables
DGMD (n = 90)
NDGMD (n = 182)
P value
Gender (male vs female)52.22% vs 47.78%54.40% vs 45.60%0.735
Age (year)52.77 ± 12.75753.4 ± 11.4930.683
Duration (year)10 (5-15)6 (2-10)< 0.01b
BMI (kg/m2)26.501 ± 3.851 24.754 ± 3.722< 0.01b
FBG (mmol/L)13.53 (8.1-16.04)9.14 (6.69-12.48)< 0.01b
Fasting C-peptide (ng/mL)1.785 (1.188-2.51)1.485 (0.89-2.023)< 0.01b
C-peptide 2h postprandial (ng/mL)3.56 (2.17- 6.213)3.145 (1.86-4.73)< 0.05a
HbA1c (%)10.353 ± 2.2019.401 ± 2.184< 0.01b
TG (mmol/L)4.85 (4.07-5.71)4.9 (4.07-5.79)0.768
TC (mmol/L)1.6 (1.19-2.705)1.43 (1.04-2.87)0.461
LDL-C (mmol/L)3.132 ± 1.0553.183 ± 1.0610.724
HDL-C (mmol/L)1.14 (1.01-1.39)1.16 (0.98-1.41)0.552
Cr (μmol/L)58.231 ± 18.47759.277 ± 19.8780.752
ALT (mmol/L)20.4 (15.175-26.6)18.75 (14.7-25.6)0.092
AST (mmol/L)18.55 (15.7-22.325)17.4 (14-22.475)0.199
25(OH)D (ng/mL)17.140 ± 5.75621.416 ± 7.234< 0.01b
DR (Y:N)124.72% vs 75.28%34.44% vs 65.56%0.105
DPN (Y:N)41.11% vs 58.89%48.90% vs 51.10%0.225
DN (Y:N)10.11% vs 89.89%11.60% vs 88.40%0.714
CP (Y:N)52.27% vs 47.73%52.75% vs 47.25%0.942
HBP (Y:N)38.20% vs 61.80%34.62% vs 65.38%0.563
MASLD (Y:N) 62.92% vs 37.08%21.98% vs 78.02%< 0.01b
aP < 0.05.
bP < 0.01. P values for differences between two groups were obtained by two-sample t-test, Mann-Whitney U-test or χ2 test.
1Y: N: Indicates that the number of people with this disease vs those without.
BMI: Body mass index; FBG: Fasting blood glucose; HbA1c: Glycated hemoglobin A1c; TG: Triglycerides; TC: Total cholesterol; LDL-c: Low density lipoprotein cholesterol; HDL-c: High density lipoprotein cholesterol; Cr: Creatinine; ALT: Alanine transminase; AST: Aspertate aminotransferase; 25(OH)D: 25-hydroxyvitamin D; DR: Diabetic retinopathy; DPN: Diabetic peripheral neuropathy; DN: Diabetic nephropathy; DCAN: Diabetic cardiac autonomic neuropathy; CP: Carotid plaque; HBP: High blood pressure; DGMD: Diabetic gastric motility disorders; MASLD: Metabolic dysfunction-associated steatotic liver disease.